Chiral Technology: Global Markets
April 20, 2010
Wellesley, Mass. – According to a new technical market research report, CHIRAL TECHNOLOGY: GLOBAL MARKETS (BIO012E) from BCC Research (www.bccresearch.com), the global market value for chiral technology was an estimated $4.5 billion in 2009, but is expected to increase to more than $5.1 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 2.8%.
The largest segment in the market, chiral synthesis, is expected to increase at a 5-year CAGR of 2.2%, from $3.6 billion in 2009 to $4 billion in 2014.
The second-largest segment, chiral analysis, is expected to reach $936 million in 2014. The market in 2009 is estimated to be $714 million. Thus, the 5-year CAGR is projected to be 5.5%.
The third-largest segment, chiral resolution, is expected to increase in value from an estimated $156 million in 2009 to $189 million in 2014, for a 5-year CAGR of 3.9%.
This study was conducted to provide an update of new developments in the chiral technology market. The previous report, published in 2004, covered only the U.S. market, but this study covers the global market of chiral products. The study was conducted to provide detailed market analysis of chiral-enabling products along with the factors affecting this market. Along with other industries, this industry saw some setbacks in 2008 due to the economic downturn, but the new advancements and the need for enantiopure compounds have always influenced the market to grow. This study looks at almost all the systems affected by these factors.
The scope of this report encompasses imaging, diagnosing, and medical markets. BCC analyzes each market and its applications by its need for diagnosis through imaging, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
Analytical companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will find this study to be of interest.
Chiral Technology: Global Markets( BIO012E )
Publish Date: Mar 2010
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum